Melvin Zhang, PhD candidate, published in the Journal of Immunology
Melvin Zhang, PhD candidate in the part-time Industrial-Biomolecular Pharmacology Training Program under the mentorship of Dr. Marion T. Kasaian in Pfizer Inc., published his dissertation work in the Journal of Immunology on December 15, 2021.
In their research, utilizing Il13-/- mice, Melvin and his collaborators showed that a cell communication molecule IL-13 regulates the activity of another one (IL-33) through modulation of IL-33’s receptor sST2.
The full article, IL-13 Controls IL-33 Activity through Modulation of ST2, is linked below:
IL-13 Controls IL-33 Activity through Modulation of ST2
